De Novo device
Tina-Quant HBA1C Gen. 2 Test System
Roche Diagnostics · Hemoglobin A1c Test System (PDJ, Class II) · First FDA decision May 23, 2013, newest May 23, 2013Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
0
Naming "Tina-Quant HBA1C Gen"
MAUDE reports
0
Brand "Tina-Quant HBA1C Gen", since 2015
PubMed studies
6
Mentioning "Tina-Quant HBA1C Gen"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Tina-Quant HBA1C Gen. 2 Test System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- TINA-QUANT HBA1C GEN. 2 TEST SYSTEMNew device typeDe Novo
DEN130002 · Decided May 23, 2013 · 59 days after receipt
Device type: Hemoglobin A1c Test System (PDJ) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Glycated Hemoglobin/Glycated ProteinNational determinationOn the books190.21Updated Oct 1, 2026
- Glycated Hemoglobin/Glycated Protein (Addition of ICD-9-CM 271.3, Intestinal disaccharidase deficiencies and disaccharide malabsorption)Coding analysisReview closedCAG-00336NUpdated Sep 14, 2026
- Glycated Hemoglobin/Glycated Protein (Addition of CPT Code 83037, Hemoglobin; glycosylated [A1c] by device cleared by FDA for home use)Coding analysisReview closedCAG-00373NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Tina-Quant HBA1C Gen", any status and sponsor, newest update first.
No registered device study names "Tina-Quant HBA1C Gen".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Tina-Quant HBA1C Gen", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PDJ
218 reports: 216 malfunction, 2 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Tina-Quant HBA1C Gen"[tiab]. The summary above synthesizes these.
- Analysis of HbA1c on an automated multicapillary zone electrophoresis system.
Rollborn N, Åkerfeldt T, Nordin G, et al. · Scand J Clin Lab Invest · 2017
- Multicenter Evaluation of a New High-Throughput HbA1c Testing Platform.
Imdahl R, Roddiger R, Casis-Saenz E · Clin Lab · 2016Evaluation Study, Multicenter Study
- [Effect of hemoglobin N Baltimore on HbA1c measurement in six methods].
Ratnam C, Yen Tran Houangkeo TH, Moutereau S, et al. · Ann Biol Clin (Paris) · 2019Review
- Hb variants in Korea: effect on HbA1c using five routine methods.
Yun YM, Ji M, Ko DH, et al. · Clin Chem Lab Med · 2017
- Ensuring HbA1c Accuracy and Variant Detection in Hemoglobin G-Coushatta and Queens Using Variant Mode Analysis.
Lee YJ, Seo JD, Hong MH, et al. · Diagnostics (Basel) · 2026
- Haemoglobin A1c: evaluation of a new HbA1c point-of-care analyser Bio-Rad in2it in comparison with the DCA 2000 and central laboratory analysers.
Yeo CP, Tan CH, Jacob E · Ann Clin Biochem · 2009Evaluation Study
Other devices of this type
Also filed under product code PDJ.
- Tosoh Automated Glycohemoglobin Analyzer HLC-723GR01Tosoh Bioscience, Inc. · 510(k) 2025
- ADVIA Chemistry Enzymatic Hemoglobin Ale (Alc_E) AssaySiemens Healthcare Diagnostics, Inc. · 510(k) 2021
- Afinion HbA1c Dx on Afinion 2Alere Technologies AS · 510(k) 2018
- Hemoglobin A1c Assay, Hemoglobin A1c Calibrators, Hemoglobin A1c ControlsAbbott Laboratories · 510(k) 2015
- H100Plus Hemoglobin Testing SystemShenzhen Lifotronic Technology Co., Ltd. · 510(k) 2026
- Medconn 8K Glycated Hemoglobin Test SystemShanghai Medconn Medical Technology Co., Ltd. · 510(k) 2026
- Medconn Glycated Hemoglobin Test systemShanghai Medconn Medical Technology Co., Ltd. · 510(k) 2025
- Hipro Glycosylated Hemoglobin (HbA1c) Test SystemShijiazhuang Hipro Biotechnology Co., Ltd. · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.